IPSAPIRONE IN THE TREATMENT OF BULIMIA-NERVOSA - AN OPEN PILOT-STUDY

Authors
GERETSEGGER C GREIMEL KV ROED IS HESSELINK JMK
Citation
C. Geretsegger et al., IPSAPIRONE IN THE TREATMENT OF BULIMIA-NERVOSA - AN OPEN PILOT-STUDY, The International journal of eating disorders, 17(4), 1995, pp. 359-363
Citations number
16
Categorie Soggetti
Psycology, Clinical",Psychiatry,Psychology,"Nutrition & Dietetics",Psychiatry
Journal title
The International journal of eating disorders → ACNP
ISSN journal
02763478
Volume
17
Issue
4
Year of publication
1995
Pages
359 - 363
Database
ISI
SICI code
0276-3478(1995)17:4<359:IITTOB>2.0.ZU;2-O
Abstract
Seventeen women who met the criteria for bulimia nervosa (DSM-III-R) w ere treated for 4 weeks in an open trial with ipsapirone, a partial 5- HT1A agonist. Bulimic symptoms diminished in 66.6% of the patients aft er only 1 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge eating attacks after 4 weeks. The mean frequency of b inges was reduced by 81% at endpoint. Ipsapirone was well tolerated. ( C) 1995 by John Wiley and Sons, Inc.